| Financial Year |
March 31 2023 |
| Monetary Funds |
377,534,544.35 |
| Held-for-trading Financial Assets |
3,555.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
442,683,383.32 |
| Advances to Suppliers |
4,003,754.26 |
| Other Receivables |
4,252,470.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
734,986,631.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,385,480.00 |
| Other Current Assets |
48,141,016.06 |
| Total Current Assets |
1,840,858,092.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
162,601,578.74 |
| Fixed Assetes |
1,634,398,109.35 |
| Under-construction Projects |
318,219,765.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
119,762,542.68 |
| R&D expenses |
-- |
| Goodwill |
66,926,223.09 |
| Long-Term Deferred and Prepaid Expenses |
111,883,640.99 |
| Deferred Income Tax Assets |
46,162,205.28 |
| Other Non-Current Assets |
46,702,166.13 |
| Sub-Total of Non-Current Assets |
2,532,296,142.74 |
| Total Assets |
4,373,154,235.66 |
| Short-Term Loans |
1,003,258,838.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
136,534,141.89 |
| Accounts Payable |
521,894,370.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,255,656.89 |
| Taxes Payable |
7,616,906.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
157,010,826.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,848,870.79 |
| Other Current Liabilities |
828,131.73 |
| Sub-Total of Current Liabilities |
1,925,066,955.00 |
| Long-term Loans |
444,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,002,775.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
528,136,692.03 |
| Total Liabilities |
2,453,203,647.03 |
| Paid-In Capital(Or Share Stock) |
338,380,666.00 |
| Capital Surplus |
932,244,979.86 |
| Surplus Reserve |
76,715,795.97 |
| LESS:Treasury Stock |
155,528,553.10 |
| Undistributed Profits |
630,779,035.22 |
| Minority Stockholder's Interest |
98,257,230.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,821,693,357.65 |
| Owner's Equity（Stockholder's Equity） |
1,919,950,588.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,373,154,235.66 |
